Dentsply Sirona Inc (XRAY):企業の財務・戦略的SWOT分析

◆英語タイトル:Dentsply Sirona Inc (XRAY) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1584
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Dentsply Sirona Inc (XRAY) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Dentsply Sirona Inc (Dentsply Sirona) formerly Dentsply International Inc, designs, develops, manufactures and markets a wide range of products for the dental market. It provides dental prosthetics, precious metal dental alloys, dental ceramics, endodontic instruments and materials, prophylaxis paste, dental sealants, ultrasonic scalers and crown and bridge materials. The company offers dental injectable anesthetics, impression materials, orthodontic appliances, dental cutting instruments and dental implants. Dentsply Sirona also provides dental handpieces, film mounts, and bone substitute or grafting materials. The company sells its products through subsidiaries and distributors in Americas, Europe, the Middle East Africa and Asia Pacific. Dentsply Sirona is headquartered in York, Pennsylvania, the US.

Dentsply Sirona Inc Key Recent Developments

Mar 09,2020 Dentsply Sirona to Present at the 2020 Barclays Global Healthcare Conference on March 11th
Mar 02,2020 Dentsply Sirona reports fourth quarter and full year 2019 results
Jan 30,2020 Lisa Yankie is Dentsply Sirona’s new Chief Human Resources Officer and Communications
Nov 07,2019 Dentsply Sirona reports third quarter 2019 financial performance

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Dentsply Sirona Inc – Key Facts
Dentsply Sirona Inc – Key Employees
Dentsply Sirona Inc – Key Employee Biographies
Dentsply Sirona Inc – Key Operational Employees
Dentsply Sirona Inc – Major Products and Services
Dentsply Sirona Inc – History
Dentsply Sirona Inc – Company Statement
Dentsply Sirona Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Dentsply Sirona Inc – Business Description
Product Category: Dental Consumables Products
Performance
Product Category: Dental Technology and Equipment Products
Performance
Product Category: Healthcare Consumable Products
Performance
Product Category: Consumables
Overview
Performance
Product Category: Technologies and Equipment
Overview
Performance
Key Stats
Geographical Segment: Europe
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: The US
Performance
R&D Overview
Dentsply Sirona Inc – Corporate Strategy
Dentsply Sirona Inc – SWOT Analysis
SWOT Analysis – Overview
Dentsply Sirona Inc – Strengths
Dentsply Sirona Inc – Weaknesses
Dentsply Sirona Inc – Opportunities
Dentsply Sirona Inc – Threats
Dentsply Sirona Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
Dentsply Sirona Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Dentsply Sirona Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Dentsply Sirona Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 09, 2020: Dentsply Sirona to Present at the 2020 Barclays Global Healthcare Conference on March 11th
Mar 02, 2020: Dentsply Sirona reports fourth quarter and full year 2019 results
Jan 30, 2020: Lisa Yankie is Dentsply Sirona’s new Chief Human Resources Officer and Communications
Nov 07, 2019: Dentsply Sirona reports third quarter 2019 financial performance
Sep 25, 2019: Dentsply Sirona announces appointment of Janet Vergis as new Board Member
Sep 03, 2019: CephX ORCA Dental AI and Dentsply Sirona announce the expansion of their integration partnership in Japan
Aug 02, 2019: Dentsply Sirona reports strong second quarter 2019 results
Jul 25, 2019: Dentsply Sirona announces a new leader for its North American commercial business
Jul 25, 2019: Dentsply Sirona offers treatment to Xingu peoples in Brazil
Jul 08, 2019: Dentsply Sirona announces appointment of Jorge M. Gomez as Chief Financial Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Dentsply Sirona Inc, Key Facts
Dentsply Sirona Inc, Key Employees
Dentsply Sirona Inc, Key Employee Biographies
Dentsply Sirona Inc, Key Operational Employees
Dentsply Sirona Inc, Major Products and Services
Dentsply Sirona Inc, History
Dentsply Sirona Inc, Subsidiaries
Dentsply Sirona Inc, Key Competitors
Dentsply Sirona Inc, Ratios based on current share price
Dentsply Sirona Inc, Annual Ratios
Dentsply Sirona Inc, Annual Ratios (Cont...1)
Dentsply Sirona Inc, Annual Ratios (Cont...2)
Dentsply Sirona Inc, Interim Ratios
Dentsply Sirona Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Dentsply Sirona Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Dentsply Sirona Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Dentsply Sirona Inc, Performance Chart (2015 - 2019)
Dentsply Sirona Inc, Ratio Charts
Dentsply Sirona Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Dentsply Sirona Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Dentsply Sirona Inc (XRAY):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Clorox Company (CLX):企業の財務・戦略的SWOT分析
    The Clorox Company (CLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Veritone, Inc. (VERI):企業の財務・戦略的SWOT分析
    Veritone, Inc. (VERI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Koc Holding AS (KCHOL):企業の財務・戦略的SWOT分析
    Koc Holding AS (KCHOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Choice Hotels International Inc:戦略・SWOT・企業財務分析
    Choice Hotels International Inc - Strategy, SWOT and Corporate Finance Report Summary Choice Hotels International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Samba Financial Group (1090):企業の財務・戦略的SWOT分析
    Samba Financial Group (1090) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • MITIE Group plc (MTO):企業の財務・戦略的SWOT分析
    MITIE Group plc (MTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Alnylam Pharmaceuticals Inc (ALNY)-製薬・医療分野:企業M&A・提携分析
    Summary Alnylam Pharmaceuticals Inc, (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines; cardiova …
  • Cineplex Inc:企業の戦略・SWOT・財務情報
    Cineplex Inc - Strategy, SWOT and Corporate Finance Report Summary Cineplex Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Spanish National Cancer Research Center-製薬・医療分野:企業M&A・提携分析
    Summary Spanish National Cancer Research Center (CNIO) is a medical research center that offers cancer research programs. The center is an integral cancer research institute which integrates basic and translational cancer research. It conducts various scientific programs which include molecular onco …
  • Asian Citrus Holdings Ltd (73):企業の財務・戦略的SWOT分析
    Asian Citrus Holdings Ltd (73) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Midea Group Co Ltd
    Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Zaraplast S.A:企業の戦略・SWOT・財務情報
    Zaraplast S.A - Strategy, SWOT and Corporate Finance Report Summary Zaraplast S.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Hospira Inc:医療機器:M&Aディール及び事業提携情報
    Summary Hospira Inc (Hospira), a subsidiary of Pfizer Inc, is a medical device company that offers injectable drugs and infusion technologies. The company offers products such as generic acute-care and oncology injectables, biosimilars, infusion systems, IV sets, IV safety devices, biosimilars, diff …
  • s.a. D’leteren n.v.:企業の戦略・SWOT・財務情報
    s.a. D'leteren n.v. - Strategy, SWOT and Corporate Finance Report Summary s.a. D'leteren n.v. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • miacom diagnostics GmbH:製品パイプライン分析
    Summary miacom diagnostics GmbH (miacom) is a molecular diagnostic company that develops and distributes molecular diagnostic tests. The company offers products such as hemoFISH, which identifies sepsis-related pathogens directly from positive blood culture bottles; respiFISH that identifies pathoge …
  • Encore Capital Group Inc:企業のM&A・事業提携・投資動向
    Encore Capital Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Encore Capital Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • HomeWorks Tri-County Electric Cooperative Inc:企業の戦略的SWOT分析
    HomeWorks Tri-County Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Proteus Digital Health Inc:企業の戦略的SWOT分析
    Proteus Digital Health Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ana Holdings Inc:企業の戦略・SWOT・財務分析
    Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Lantern Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lantern Pharma Inc (Lantern Pharma) is a clinical stage pharmaceutical company that discovers and develops therapies for various cancer types. The company’s pipeline products Irofulven-1 and Irofulven-2 are non-hormone, non-chemotherapy, next-generation DNA damage repair inhibitors. Its othe …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆